| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |